| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/27/2010 | US20100129381 Nucleotide sequences coding fibroblast growth factor-19 specific immunoglobulin for use in prevention and treatment of tumors, cancer and/or cell proliferative disorders |
| 05/27/2010 | US20100129380 Antibodies Against IL-25 |
| 05/27/2010 | US20100129373 Vegf-specific human antibody |
| 05/27/2010 | US20100129368 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof |
| 05/27/2010 | US20100129360 Antibodies against human interleukin-13 and uses therefor |
| 05/27/2010 | US20100129342 Human Growth and Differentiation Factor GDF-5 |
| 05/27/2010 | US20100129337 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| 05/27/2010 | US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses |
| 05/27/2010 | CA2744243A1 Peptide synthesis using enzymatic activation and coupling |
| 05/27/2010 | CA2743634A1 Filamentous fungi with impaired ptrb activity for altered protein production |
| 05/27/2010 | CA2742792A1 Prediction and prevention of preeclampsia |
| 05/26/2010 | EP2189531A1 Novel dna fragment, recombinant vector containing the same, transformant transformed therewith and utilization of the same |
| 05/26/2010 | EP2189529A1 Recombinant mammalian cells, method of producing recombinant mammalian cells and method of producing target protein |
| 05/26/2010 | EP2189526A1 Antibody binding specifically to tdp-43 aggregate |
| 05/26/2010 | EP2189521A1 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
| 05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
| 05/26/2010 | EP2189474A1 A plant height regulatory gene and uses thereof |
| 05/26/2010 | EP2189471A1 Foxm1 peptide and medicinal agent comprising the same |
| 05/26/2010 | EP2188382A1 Glycosylation profile analysis |
| 05/26/2010 | EP2188376A2 Molecule production by photosynthetic organisms |
| 05/26/2010 | EP2188371A2 Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| 05/26/2010 | EP2187965A1 Psma binding ligand-linker conjugates and methods for using |
| 05/26/2010 | EP1664292B1 Animal product free media and processes for obtaining a botulinum toxin |
| 05/26/2010 | EP1599596B1 Combinatorial dna library for producing modified n -glycans in lower eukaryotes |
| 05/26/2010 | EP1448602B1 Modified anti-tnf alpha antibody |
| 05/26/2010 | EP1290194B1 Production of secreted polypeptides |
| 05/26/2010 | EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 05/26/2010 | EP1082875B1 Improved brush block housing for propeller deicing system |
| 05/26/2010 | CN1928109B Preparation method of natural multi-component antibacterial protein fermentation liquor |
| 05/26/2010 | CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 05/26/2010 | CN1896266B Preparation of bioactive peptide for inhibiting meat fat oxidation |
| 05/26/2010 | CN1735691B Fermentation process using specific oxygen uptake rates as a process control |
| 05/26/2010 | CN1735683B Methods and materials for the production of D-lactic acid in yeast |
| 05/26/2010 | CN1680426B Purification method which prevents denaturation of an antibody |
| 05/26/2010 | CN1665934B GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/26/2010 | CN1661015B Glutathione synthetase-coding gene of candida utilis |
| 05/26/2010 | CN1596313B Humanized collagen antibodies and related methods |
| 05/26/2010 | CN1578678B Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 05/26/2010 | CN1571838B Gene overexpression system |
| 05/26/2010 | CN1526820B Promotor for expressing gene in fungal cell |
| 05/26/2010 | CN1468308B Anti-TNF antibodies, compositions, methods and uses |
| 05/26/2010 | CN1425066B Novel stra6 polypeptides |
| 05/26/2010 | CN1406245B Method of eliminating human serum albumin polymers |
| 05/26/2010 | CN101715490A Method for production of glutathione or gamma-glutamylcysteine |
| 05/26/2010 | CN101715484A Method for producing dipeptide |
| 05/26/2010 | CN101712975A Deodorized fish peptide and preparation method thereof |
| 05/26/2010 | CN101712974A Method for preparing egg albumin polypeptide |
| 05/26/2010 | CN101712956A Promoter nucleic acid derived from corynebacterium genus bacteria, expression cassette comprising the promoter and vector comprising the cassette, host cell comprising the vector and method for expressing a gene using the cell |
| 05/26/2010 | CN101712955A Process for producing physiologically active protein using genetically modified silkworm |
| 05/26/2010 | CN101712722A Glp-1 fusion proteins |
| 05/26/2010 | CN101712720A Human antibodies that bind human TNF alpha |
| 05/26/2010 | CN101712591A Process for extracting unsaturated fatty acid and polypeptide in peanuts |
| 05/26/2010 | CN101113463B Preparation method of lactic acid streptostacin |
| 05/26/2010 | CN101096698B Preparation technology for soybean oligopeptide with high F-value |
| 05/25/2010 | USRE41356 Hepatitis C inhibitor tri-peptides |
| 05/25/2010 | US7723563 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
| 05/25/2010 | US7723506 Heat shock protein regulatory sequences for enhancing expression of heterologus genes in cells; improving transcription from exogenous genes |
| 05/25/2010 | US7723505 EAAT2 promoter and uses thereof |
| 05/25/2010 | US7723502 a codon optimized and stabilized polynucleotide that codes for polypeptides; oxidoreductase enzymes exhibiting long-wavelength light emission, as well as improved thermostability and higher expression levels in mammalian cell systems |
| 05/25/2010 | US7723497 polynucleotide having nucleic acid sequences, encoding and expressing calcium-independent phospholipase A2 epsilon (iPLA2 epsilon ); for catalysis and hydrolysis of lipids in living cell biosystem; iPLA2 epsilon as a pharmacological target in drug screening anti-obesity drugs |
| 05/25/2010 | US7723492 Method for the detection of sepsis using procalcitonin-3-116 |
| 05/25/2010 | US7723490 Process for correction of a disulfide misfold in Fc molecules |
| 05/25/2010 | US7723485 Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates |
| 05/25/2010 | US7723482 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |
| 05/25/2010 | US7723479 BSL3 polypeptides |
| 05/25/2010 | US7723478 DKR polypeptides |
| 05/25/2010 | US7723298 Cytokine receptor |
| 05/25/2010 | US7723296 Coupling monosaccharide into glycoprotein; oxidation; increasing therapeutic efficiency |
| 05/25/2010 | US7723270 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 05/25/2010 | US7723269 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 05/25/2010 | US7723109 Expression of spider silk proteins |
| 05/25/2010 | US7723098 Method of constructing host and method of producing heterologous protein |
| 05/25/2010 | US7723093 Used for removing cross contamination from PCR reaction products byreacting a uracil-containing DNA substrate with the uracil-DNA glycosylase at 50 degrees C. or lower, and conducting PCR reaction. |
| 05/25/2010 | US7723082 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |
| 05/25/2010 | US7723076 Culturing a transformed cell line containing a polynucleotide expression vector encoding the target molecule in a medium containing a labeled precursor that selectively labels only the particular amino acid at a functional site of the target molecule; every occurrence of the acid is labeled |
| 05/25/2010 | US7723075 Methods of screening for TRPM5 modulators |
| 05/25/2010 | US7723074 Nucleic acid molecules encoding prostaglandin receptor proteins |
| 05/25/2010 | US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1 |
| 05/25/2010 | US7723072 Using cadmium-zinc resistance (CZR) protein as modulator for enhancing exogenous gene expression |
| 05/25/2010 | US7723071 DNA molecules encoding opioid receptors and methods of use thereof |
| 05/25/2010 | US7723070 Adding an desired amino acid analog to a medium containing a host cell with a vector coding for aminoacyl-tRNA synthetase and a vector coding for the polypeptide of interest; and growing the cell to produce the modified polypeptide |
| 05/25/2010 | US7723069 Site specific incorporation of phosphoserine into polypeptides using phosphoseryl-tRNA synthetase |
| 05/25/2010 | US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 05/25/2010 | US7723067 Process for producing transglutaminase |
| 05/25/2010 | US7722889 Plasmodium liver stage antigens |
| 05/25/2010 | US7722888 Streptococcus pneumoniae proteins and nucleic |
| 05/25/2010 | US7722880 polynucleotide encodes a protein for inducing an immune response; use as vaccines; drug targeting to specific protein; bactericides; veterinary medicine |
| 05/25/2010 | US7722877 Coccidiosis vaccines |
| 05/25/2010 | US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells |
| 05/25/2010 | US7722872 Treatment of cancer with antibodies to costimulating polypeptide of T cells |
| 05/25/2010 | US7722870 Method of treating fibroproliferative disorders |
| 05/25/2010 | US7722869 purified scFv peptide comprising a VH domain and a VL domain linked by an amino acid spacer, and scFv peptide comprises a substitution of an amino acid in the VH domain at the position corresponding to C28 |
| 05/25/2010 | US7722867 Nucleotide sequences coding chimeric immunoglobulin specific for epidermal growth factor receptor; treatment and prevention of cell proliferative disorders |
| 05/25/2010 | CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 05/25/2010 | CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds |
| 05/25/2010 | CA2313248C Process for the production of naturally folded and secreted proteins by co-secretion of molecular chaperones |
| 05/25/2010 | CA2241786C Novel amp activated protein kinase |
| 05/25/2010 | CA2238613C Consensus phytases |
| 05/25/2010 | CA2233538C Commercial production of aprotinin in plants |
| 05/25/2010 | CA2218857C Clostridial toxin derivatives able to modify peripheral sensory afferent functions |